Overview

To Evaluate the Clinical Efficacy and Safety of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children

Status:
Not yet recruiting

Trial end date:
2024-05-01

Target enrollment:

Participant gender:

Summary

To evaluate the clinical efficacy and safety of recombinant human interferon ω spray in treatment of viral upper respiratory tract infection in children aged by 3-12 years, and to explore the appropriate usage and dosage of the drug in treatment of upper respiratory tract infection caused by viruses.

Phase:

Phase 2

Details

Lead Sponsor:

Seventh Medical Center of PLA General Hospital

Collaborators:

The General Hospital of Central Theater Command
The General Hospital of Northern Theater Command

Treatments:

Interferons